Gts Securities LLC Ab Cellera Biologics Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$2.39 - $3.49 $8,126 - $11,866	3,400 Added 24.29%	17,400 $45,000
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $273 - $473	100 Added 0.72%	14,000 $41,000
Q1 2024 May 15, 2024	SELL	$4.29 - $5.97 $42,042 - $58,506	-9,800 Reduced 41.35%	13,900 $62,000
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $25,415 - $38,545	-6,500 Reduced 21.52%	23,700 $135,000
Q3 2023 Nov 15, 2023	BUY	$4.6 - $7.95 $138,920 - $240,090	30,200 New	30,200 $138,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $756M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.